Ç. SOYDAL Et Al. , "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma," Erupoean Association of Nuclear Medicine , vol.44, 2017
SOYDAL, Ç. Et Al. 2017. Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma. Erupoean Association of Nuclear Medicine .
SOYDAL, Ç., ÖZKAN, E., NAK, D., ELHAN, A. H., KÜÇÜK, N. Ö., & KIR, K. M., (2017). Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma . Erupoean Association of Nuclear Medicine
SOYDAL, ÇİĞDEM Et Al. "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma," Erupoean Association of Nuclear Medicine, 2017
SOYDAL, ÇİĞDEM Et Al. "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma." Erupoean Association of Nuclear Medicine , 2017
SOYDAL, Ç. Et Al. (2017) . "Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma." Erupoean Association of Nuclear Medicine .
@conferencepaper{conferencepaper, author={ÇİĞDEM SOYDAL Et Al. }, title={Risk factors for predicting osteoporosis in patients who receive tsh-supressive levothyroxine treatment for differantiated thyroid carcinoma}, congress name={Erupoean Association of Nuclear Medicine}, city={}, country={}, year={2017}}